AJP - GI Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol (December 4, 2002). doi:10.1152/ajpgi.00431.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/4/G713    most recent
00431.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zou, L.
Right arrow Articles by Kone, B. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zou, L.
Right arrow Articles by Kone, B. C.

Articles in PresS, published online ahead of print December 4, 2002
Am J Physiol Gastrointest Liver Physiol, 10.1152/ajpgi.00431.2002
Submitted on October 10, 2002
Accepted on December 2, 2002

Effects of NF-{kappa}B Inhibition on Mesenteric Ischemia-reperfusion Injury

Lei Zou1, Bashir Attuwaybi2, and Bruce C. Kone1*

1 Department of Internal Medicine and of Integrative Biology and Pharmacology, The University of Texas Medical School at Houston, Houston, TX, USA; Trauma Research Center, The University of Texas Medical School at Houston, Houston, TX, USA
2 Department of Surgery, The University of Texas Medical School at Houston, Houston, TX, USA; Trauma Research Center, The University of Texas Medical School at Houston, Houston, TX, USA

* To whom correspondence should be addressed. E-mail: Bruce.C.Kone{at}uth.tmc.edu.

Mesenteric ischemia-reperfusion (I/R) injury is a serious complication of shock. Because activation of NF-{kappa}B has been implicated in this process, we treated rats with vehicle or the I{kappa}B-{alpha} inhibitor BAY 11-7085 (25 mg/kg I.P.) one hour before mesenteric I/R (45 min of ischemia; 30 min or 6 h reperfusion) and examined the ileal injury response. Vehicle-treated I/R rats exhibited severe mucosal injury, increased myeloperoxidase (MPO) activity, increased expression of IL-6 and ICAM-1 protein, and a biphasic peak of NF-{kappa}B DNA binding activity during the 30 min and 6 h reperfusion course. In contrast, BAY 11-7085-pretreated I/R rats exhibited less histologic injury and less IL-6 and ICAM-1 protein expression at 30 min of reperfusion, but worse histologic injury at 6 h of reperfusion compared to vehicle-treated I/R rats. Studies with phosphorylation site-specific antibodies demonstrated that I{kappa}B-{alpha} phosphorylation at Ser-32, Ser-36 was induced at 30 min of reperfusion, whereas tyrosine phosphorylation of I{kappa}B-{alpha} was induced at 6 h of reperfusion. BAY 11-7085 inhibited the former, but not the latter phosphorylation pathway, whereas {alpha}-melanocyte stimulating hormone, which is effective in limiting late I/R injury to the intestine, inhibited tyrosine phosphorylation of I{kappa}B-{alpha}. Thus, NF-{kappa}B appears to play an important role in both the generation and the resolution of intestinal I/R injury through different activation pathways.




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. C. Kurtz, S. L. Lindell, M. J. Mangino, and H. V. Carey
Hibernation confers resistance to intestinal ischemia-reperfusion injury
Am J Physiol Gastrointest Liver Physiol, November 1, 2006; 291(5): G895 - G901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1979 by the American Physiological Society.